NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (Biomechanical Adaptations)
2 other identifiers
interventional
20
1 country
1
Brief Summary
An affordable and easy to use gait-assistive device for stroke survivors to use at home is yet to be developed. This study is intended to modify the current design of the NewGait device to specifically work for stroke survivors based on feedback from patients and clinicians. Consequently, conducting a short-term biomechanical gait study is planned to determine the usability and functionality of the NewGait device compared to other comparative devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Apr 2024
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2024
CompletedResults Posted
Study results publicly available
December 23, 2025
CompletedDecember 23, 2025
December 1, 2025
8 months
February 13, 2024
December 5, 2025
December 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Gait Speed
Changes in gait speed (from baseline) as measured using the 10 Meter Walk Test between the experimental (NewGait) and control conditions. Participants were timed during the 10 Meter Walk Test to determine their self-selected gait speed while walking overground in a hallway. In this test, participants walked down a 14 meter walkway, and a stopwatch was used to time how long it took participants to cross the intermediate 10 meter distance. The baseline measure for the first device was taken immediately prior to the intervention. Participants then wore the first device, and the during-training measure was taken immediately. After this, participants received training with the device for about 15 minutes, following which, the device was removed and the post-intervention measure was taken immediately for the first device. Participants then rested for 20-30 minutes. This entire process was repeated with the second device. All measures were obtained on the same day.
Up to 2 hours
Ankle Muscle Activation
Changes in ankle muscle activation of the leg muscles as measured using surface electromyography between the experimental (NewGait) and control conditions. Muscle activation ranges from 0 to no upper limit, and higher activation meant that the muscle was being used more. The baseline measure for the first device was taken immediately prior to the intervention. Participants then wore the first device, and the during-training measure was taken immediately. After this, participants received training with the device for about 15 minutes, following which, the device was removed, and the post-intervention measure was taken immediately for the first device. Participants then rested for 20-30 minutes. This entire process was repeated with the second device. All measures were obtained on the same day.
Up to 2 hours
Secondary Outcomes (1)
Changes in Paretic Leg Propulsive Force
Up to 2 hours
Other Outcomes (3)
Changes in Paretic Leg Loading (i.e., Vertical Ground Reaction Force)
Up to 2 hours
Changes in Other Lower Extremity Muscle Activation
Up to 2 hours
Muscle Coordination
Up to 2 hours
Study Arms (2)
NewGait
EXPERIMENTALParticipants will put on the NewGait device and walk on the treadmill and overground. Participants may receive biofeedback of their gait patterns to engage them in the training.
Control
OTHERParticipants will put on the Control device and walk on the treadmill and over ground. Participants may receive biofeedback of their gait patterns to engage them in the training.
Interventions
Eligibility Criteria
You may qualify if:
- Unilateral cortical or subcortical stroke
- Chronic stroke (≥ 6 months) At least 6 months following their first unilateral stroke
- Able to walk independently with/without assistive devices for 5-10 mins (\~150m)
- No significant cognitive deficits as determined by the Mini Mental State Examination (MMSE) score (score≥ 22)
You may not qualify if:
- Cerebellar stroke
- Traumatic or vascular brain injury
- History of unstable heart condition, uncontrolled diabetes/hypertension
- History of a recent lower-extremity trauma or fracture
- History of a recent significant orthopedic or neurological conditions that could limit walking ability (e.g., multiple sclerosis, total knee replacement)
- Documented history of significant spatial neglect
- ankle joint contractures or significant spasticity in the lower limbs
- History of a recent Botulinum Toxin (Botox) injection to the lower-extremity muscles (≤ 3 months)
- Pregnant or actively planning to become pregnant (self-reported)- Inability to communicate or unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Physical Medicine & Rehabilitation 325 E Eisenhower Pkwy Suite 3011
Ann Arbor, Michigan, 48108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Chandramouli Krishnan
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Chandramouli Krishnan, PT, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
February 13, 2024
First Posted
February 21, 2024
Study Start
April 1, 2024
Primary Completion
December 9, 2024
Study Completion
December 9, 2024
Last Updated
December 23, 2025
Results First Posted
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share